Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
FDA purchases digiM I2S software for the assessment of product quality attributes 2024-01-24 23:37
ŸNSECT GRANTED FIRST APPROVAL OF ITS KIND, TO COMMERCIALISE MEALWORM PROTEINS FOR DOG FOOD IN THE USA 2024-01-24 22:09
Wellysis Goes Global with ECG Monitor 'S-Patch', Enters US and Indian Markets 2024-01-24 22:00
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit 2024-01-24 21:32
Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy 2024-01-24 21:30
Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI 2024-01-24 21:00
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases' 2024-01-24 20:00
SHL Medical partners with SteriPack Group to set up final assembly service 2024-01-24 18:00
Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707 for Solid Tumors 2024-01-24 17:49
Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne 2024-01-24 16:50
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions 2024-01-24 16:00
Onward Therapeutics Announces Enrollment of Phase 1 Clinical Trial of a Novel Bispecific Antibody (OT-A201) Targeting Two Immune Checkpoints 2024-01-24 15:00
Harbour BioMed Announces IND Clearance for HBM9027 in the U.S. 2024-01-24 12:40
WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs) 2024-01-24 11:37
PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors 2024-01-24 10:01
Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide 2024-01-24 10:00
INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness 2024-01-24 08:22
Datasea Pre-Announces First Half 2024 Revenue of $18.2 Million, a 1,037.5% Year-Over-Year Increase 2024-01-23 22:35
Rhino Rescue Speeds into the Future of First-Aid Supplies with New Year Resolutions for 2024 2024-01-23 22:15
IMG Mobile App Now Available with 24/7 Access to Coverage for All Customers 2024-01-23 22:00
1 144 145 146 147 148 1606